309 related articles for article (PubMed ID: 16979139)
1. Partial agonists as therapeutic agents at neuronal nicotinic acetylcholine receptors.
Hogg RC; Bertrand D
Biochem Pharmacol; 2007 Feb; 73(4):459-68. PubMed ID: 16979139
[TBL] [Abstract][Full Text] [Related]
2. Sazetidine-A, a novel ligand that desensitizes alpha4beta2 nicotinic acetylcholine receptors without activating them.
Xiao Y; Fan H; Musachio JL; Wei ZL; Chellappan SK; Kozikowski AP; Kellar KJ
Mol Pharmacol; 2006 Oct; 70(4):1454-60. PubMed ID: 16857741
[TBL] [Abstract][Full Text] [Related]
3. [Role of smoking and nicotine in neuropsychiatric disorders: evidence for therapeutic role of nicotinic acetylcholine receptors].
Miyata H
Nihon Shinkei Seishin Yakurigaku Zasshi; 2008 Aug; 28(4):149-58. PubMed ID: 18800618
[TBL] [Abstract][Full Text] [Related]
4. Modulators of nicotinic acetylcholine receptors as analgesics.
Jain KK
Curr Opin Investig Drugs; 2004 Jan; 5(1):76-81. PubMed ID: 14983978
[TBL] [Abstract][Full Text] [Related]
5. [Nicotine acetylcholine receptors and neuropsychiatric disorders].
Vázquez-Palacios G; Bonilla-Jaime H
Rev Neurol; 2004 Dec 16-31; 39(12):1146-60. PubMed ID: 15625635
[TBL] [Abstract][Full Text] [Related]
6. Central nicotinic receptors: structure, function, ligands, and therapeutic potential.
Romanelli MN; Gratteri P; Guandalini L; Martini E; Bonaccini C; Gualtieri F
ChemMedChem; 2007 Jun; 2(6):746-67. PubMed ID: 17295372
[TBL] [Abstract][Full Text] [Related]
7. Angiogenic activity of nicotinic acetylcholine receptors: implications in tobacco-related vascular diseases.
Egleton RD; Brown KC; Dasgupta P
Pharmacol Ther; 2009 Feb; 121(2):205-23. PubMed ID: 19063919
[TBL] [Abstract][Full Text] [Related]
8. Rationale, pharmacology and clinical efficacy of partial agonists of alpha4beta2 nACh receptors for smoking cessation.
Rollema H; Coe JW; Chambers LK; Hurst RS; Stahl SM; Williams KE
Trends Pharmacol Sci; 2007 Jul; 28(7):316-25. PubMed ID: 17573127
[TBL] [Abstract][Full Text] [Related]
9. Structural and functional diversity of native brain neuronal nicotinic receptors.
Gotti C; Clementi F; Fornari A; Gaimarri A; Guiducci S; Manfredi I; Moretti M; Pedrazzi P; Pucci L; Zoli M
Biochem Pharmacol; 2009 Oct; 78(7):703-11. PubMed ID: 19481063
[TBL] [Abstract][Full Text] [Related]
10. Nicotinic acetylcholine receptor system and neuropsychiatric disorders.
Singh A; Potter A; Newhouse P
IDrugs; 2004 Dec; 7(12):1096-103. PubMed ID: 15599803
[TBL] [Abstract][Full Text] [Related]
11. Cholinergic nicotinic receptors: competitive ligands, allosteric modulators, and their potential applications.
Romanelli MN; Gualtieri F
Med Res Rev; 2003 Jul; 23(4):393-426. PubMed ID: 12710018
[TBL] [Abstract][Full Text] [Related]
12. Antidepressant-like effects of nicotinic acetylcholine receptor antagonists, but not agonists, in the mouse forced swim and mouse tail suspension tests.
Andreasen JT; Olsen GM; Wiborg O; Redrobe JP
J Psychopharmacol; 2009 Sep; 23(7):797-804. PubMed ID: 18583432
[TBL] [Abstract][Full Text] [Related]
13. Allosteric modulation of Torpedo nicotinic acetylcholine receptor ion channel activity by noncompetitive agonists.
Maelicke A; Coban T; Storch A; Schrattenholz A; Pereira EF; Albuquerque EX
J Recept Signal Transduct Res; 1997; 17(1-3):11-28. PubMed ID: 9029479
[TBL] [Abstract][Full Text] [Related]
14. Toxin insights into nicotinic acetylcholine receptors.
Dutertre S; Lewis RJ
Biochem Pharmacol; 2006 Sep; 72(6):661-70. PubMed ID: 16716265
[TBL] [Abstract][Full Text] [Related]
15. Nicotinic acetylcholine receptors as drug targets.
Hogg RC; Bertrand D
Curr Drug Targets CNS Neurol Disord; 2004 Apr; 3(2):123-30. PubMed ID: 15078187
[TBL] [Abstract][Full Text] [Related]
16. Neuronal nicotinic receptors: from structure to pathology.
Gotti C; Clementi F
Prog Neurobiol; 2004 Dec; 74(6):363-96. PubMed ID: 15649582
[TBL] [Abstract][Full Text] [Related]
17. α4β2* neuronal nicotinic receptor ligands (agonist, partial agonist and positive allosteric modulators) as therapeutic prospects for pain.
Nirogi R; Goura V; Abraham R; Jayarajan P
Eur J Pharmacol; 2013 Jul; 712(1-3):22-9. PubMed ID: 23660369
[TBL] [Abstract][Full Text] [Related]
18. Competitive neuronal nicotinic receptor antagonists: a new direction for drug discovery.
Dwoskin LP; Crooks PA
J Pharmacol Exp Ther; 2001 Aug; 298(2):395-402. PubMed ID: 11454899
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of varenicline for smoking cessation.
Hays JT; Ebbert JO; Sood A
Am J Med; 2008 Apr; 121(4 Suppl 1):S32-42. PubMed ID: 18342165
[TBL] [Abstract][Full Text] [Related]
20. Potential applications of nicotinic ligands in the laboratory and clinic.
Dani JA; De Biasi M; Liang Y; Peterson J; Zhang L; Zhang T; Zhou FM
Bioorg Med Chem Lett; 2004 Apr; 14(8):1837-9. PubMed ID: 15050611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
